Markets:

Overview

News

Currencies

International

Treasuries

Nanobiotix S.A. - ADSs (NQ:NBTX)

34.77 -1.99 (-5.41%)

Streaming Delayed Price Updated: 2:22 PM EDT, Jun 3, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Nanobiotix S.A. - ADSs

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital

December 08, 2021

From Nanobiotix

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 08, 2021

Gainers Lexaria Bioscience (NASDAQ:LEXX) shares increased by 30.28% to $6.41 during Wednesday's pre-market session. The company's market cap stands at $36.7...

Via Benzinga

NANOBIOTIX to Present at the 4th Annual Evercore ISI HealthCONx Conference

November 17, 2021

From NANOBIOTIX

Via Business Wire

NANOBIOTIX Announces New Preclinical Data Highlighting NBTXR3 Immune Priming and Checkpoint Inhibitor Combination

November 09, 2021

From NANOBIOTIX

Via Business Wire

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline ↗

August 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance ↗

November 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:...

Via Benzinga

Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital

November 08, 2021

From Nanobiotix

Via Business Wire

NANOBIOTIX to Participate in a Fireside Chat at the Jefferies London Healthcare Conference

November 03, 2021

From Nanobiotix

Via Business Wire

The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children ↗

October 26, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Anaptys Sells Royalties Due On Cancer Drug Jemperli To Sagard For $250M...

Via Benzinga

NANOBIOTIX Announces 18.1 Month Median Overall Survival for 41 Evaluable Elderly and Frail Patients With HNSCC in Phase I Expansion Evaluating Nbtxr3 as a Single Agent Activated by Radiotherapy

October 24, 2021

From NANOBIOTIX

Via Business Wire

NANOBIOTIX Provides Third Quarter Operational and Financial Update

October 20, 2021

From NANOBIOTIX

Via Business Wire

The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More ↗

October 24, 2021

Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength...

Via Benzinga

Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital

October 08, 2021

From Nanobiotix

Via Business Wire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 07, 2021

Gainers Nanobiotix (NASDAQ:NBTX) shares rose 13.2% to $12.0 during Thursday's regular session. The market value of their outstanding shares is at $417.9 million....

Via Benzinga

NANOBIOTIX to Present First Survival Data From Priority Head and Neck Cancer Program Among Five Presentations at the 2021 Annual Meeting of the American Society for Radiation Oncology

October 06, 2021

From NANOBIOTIX

Via Business Wire

NANOBIOTIX Announces Red Journal Publication of Preclinical Data Showing Radioenhancer NBTXR3 May “Reprogram” the Tumor Microenvironment to Overcome Anti-PD-1 Resistance and Evoke Abscopal Effect

September 28, 2021

From NANOBIOTIX

Via Business Wire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 10, 2021

Gainers IVERIC bio (NASDAQ:ISEE) shares increased by 63.11% to $14.18 during Friday's regular session. IVERIC bio's stock is trading at a volume of 120.3 million...

Via Benzinga

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout ↗

October 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (...

Via Benzinga

The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO ↗

October 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 10, 2021

Gainers IVERIC bio (NASDAQ:ISEE) stock increased by 65.36% to $14.37 during Friday's pre-market session. The company's market cap stands at $1.4 billion. T2...

Via Benzinga

The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug ↗

September 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...

Via Benzinga

Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital as of August 31, 2021

September 09, 2021

From Nanobiotix

Via Business Wire

The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold ↗

September 17, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16) Bicycle Therapeutics plc (...

Via Benzinga

NANOBIOTIX Provides Business Update and Reports Financial Results for the First Half of 2021

September 08, 2021

From NANOBIOTIX S.A.

Via Business Wire

The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout ↗

September 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE...

Via Benzinga

Earnings Scheduled For September 8, 2021 ↗

September 08, 2021

Companies Reporting Before The Bell • Nanobiotix (NASDAQ:NBTX) is likely to report earnings for its first quarter. • Waterdrop (NYSE:WDH) is expected to report...

Via Benzinga

Nanobiotix to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

September 07, 2021

From NANOBIOTIX

Via Business Wire

Earnings Scheduled For September 3, 2021 ↗

September 03, 2021

Companies Reporting After The Bell • IRSA Propiedades (NASDAQ:IRCP) is projected to report earnings for its fourth quarter. • Nanobiotix (NASDAQ:NBTX) is...

Via Benzinga

Nanobiotix Provides Second Quarter Operational and Financial Update

July 20, 2021

From NANOBIOTIX

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 14, 2021

Gainers AcelRx Pharmaceuticals (NASDAQ:ACRX

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.